Nanjing MeiRui Pharma Co., Ltd.
Nanjing MeiRui Pharma Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in Nanjing, China. Established in 2003, the company has rapidly expanded its operations across major regions in Asia and beyond, focusing on the development and manufacturing of high-quality pharmaceutical products. Specialising in active pharmaceutical ingredients (APIs) and finished dosage forms, Nanjing MeiRui Pharma is recognised for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic medications and specialty pharmaceuticals, which are distinguished by their efficacy and safety profiles. With a strong market position, Nanjing MeiRui Pharma has achieved significant milestones, including various certifications and partnerships that underscore its reputation for excellence in the pharmaceutical sector.
DitchCarbon Score
How does Nanjing MeiRui Pharma Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nanjing MeiRui Pharma Co., Ltd.'s score of 56 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nanjing MeiRui Pharma Co., Ltd.'s reported carbon emissions
Nanjing MeiRui Pharma Co., Ltd., headquartered in China, currently does not have available carbon emissions data or specific reduction targets. As such, there are no reported figures for their carbon footprint in terms of kg CO2e across Scope 1, 2, or 3 emissions. The company has not outlined any significant climate commitments or initiatives aimed at reducing greenhouse gas emissions. In the context of the pharmaceutical industry, it is increasingly important for companies to establish clear climate strategies and reduction targets to align with global sustainability goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Nanjing MeiRui Pharma Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
